SR9009 (Stenabolic) Research Solution in Canada
This listing supplies SR9009 (Stenabolic) as a labelled liquid research solution for laboratory identification, analytical comparison, and controlled research workflows. It is not a dietary supplement, medication, or product for human or veterinary use.
Product specifications
| Compound | SR9009 (Stenabolic) |
|---|---|
| Classification | synthetic REV-ERB ligand; it is not a SARM |
| Listed concentration | 20 mg/mL |
| Volume | 30 mL |
| Total listed compound | 600 mg |
| Format | Labelled liquid research solution |
| Documentation | See Testing & COA Documentation |
Compound identity and classification
SR9009 (Stenabolic) is classified as a synthetic REV-ERB ligand; it is not a SARM. Correct classification matters when comparing research catalogues: related compounds can appear beside SARMs without sharing the same primary target or mechanism.
SR9009 appears mainly in preclinical and cell-based research concerning circadian biology, metabolism, and REV-ERB signalling. A 2019 mechanistic study reported that SR9009 can produce effects in cells lacking REV-ERB-alpha and REV-ERB-beta, an important limitation when interpreting it solely as a selective REV-ERB probe. Established human clinical evidence is lacking.
Published findings should be read as study-specific observations, not as proof of efficacy, safety, or a recommendation for use outside an authorized research setting.
Understanding the listed concentration
The listed concentration of 20 mg/mL describes the product format. In a 30 mL bottle, this corresponds to 600 mg of listed compound in total. Concentration information supports inventory control and analytical planning; it is not dosage, cycle, or administration guidance.
Material-batch documentation
Material-batch requires review of the document fields by compound. Contact support to confirm the documentation currently available for this listing.
To request available documentation, email [email protected] with the product name or order number. See our Testing & COA Documentation page for help interpreting identity, purity, method, and documentation details.
Research-use boundaries and handling
This product is sold strictly for laboratory and research purposes. It is not intended for human consumption, therapeutic use, bodybuilding use, athletic performance use, veterinary use, or the diagnosis, treatment, cure, or prevention of disease.
Keep the container sealed and follow the storage information on its label or accompanying documentation. Record the product name, concentration, receipt date, and applicable documentation in laboratory inventory records. Contact support for product-specific documentation or handling questions.
Frequently asked questions
What does this bottle contain?
It contains one labelled 30 mL liquid research solution of SR9009 (Stenabolic) at a listed concentration of 20 mg/mL, representing 600 mg of listed compound in total.
Is SR9009 a SARM?
SR9009 (Stenabolic) is a synthetic REV-ERB ligand; it is not a SARM. This classification is provided for catalogue accuracy and should not be interpreted as a safety or efficacy claim.
Can I request a COA?
Yes, where applicable. COA documentation relates to the applicable incoming material batch. Availability varies by compound; contact support to confirm what is currently available.
Does this page provide dosage or cycle guidance?
No. Concentration describes the supplied research format only. Canada SARMs does not provide dosage, cycle, administration, bodybuilding, or medical guidance.
Where can I compare research documentation?
Review the Research Library, the Complete SARMs Guide, and the FAQ.
Reviews
There are no reviews yet.